...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Td waterhouse
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Not sure where these Rumours are coming from other than the discussion LED had with DM at the bloom and burton conference this past May but Zenith just completed a PP at $2usd so that’s pretty low if a buyout is in the works at $10 to $15 usd  anything is possible i suppose

 

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply